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75015 Paris, France; 3Department of Cancer and Cell Biology, Metabolic Diseases Institute, University of Cincinnati, Cincinnati,
Ohio 45237, USA; 4Catalan Institute of Oncology, Bellvitge Biomedical Research Institute, Institut d’Investigació Biomèdica de
Bellvitge (IDIBELL), 08908 Hospitalet de Llobregat, Barcelona, Spain
Impairment of ribosome biogenesis leads to p53 induction and cell cycle arrest, a checkpoint involved in human
disease. Induction of p53 is attributed to the binding and inhibition of human double minute 2 (Hdm2) by a subset
of ribosomal proteins (RPs): RPS7, RPL5, RPL11, and RPL23. However, we found that only RPL11 or RPL5, in
a mutually dependent manner, elicit this response. We show that depletion of RPS7 or RPL23, like depletion of
other RPs, except for RPL11 and RPL5, induces a p53 response and that the effects of RPS7 and RPL23 on p53
induction reported earlier may be ascribed to inhibition of global translation. Moreover, we made the surprising
observation that codepletion of two essential RPs, one from each subunit, but not the same subunit, leads to
suprainduction of p53. This led to the discovery that the previously proposed RPL11-dependent mechanism of p53
induction, thought to be caused by abrogation of 40S biogenesis and continued 60S biogenesis, is still operating,
despite abrogation of 60S biogenesis. This response leads to both a G1 block and a novel G2/M block not observed
when disrupting either subunit alone. Thus, induction of p53 is mediated by distinct mechanisms, with the data
pointing to an essential role for ribosomal subunits beyond translation.
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The ribosome plays a unique role in the maintenance of
the species, translating mRNAs into functional proteins
(Watson 1964). Moreover, it is known that the affinity of
the translational apparatus for any single mRNA species
is unique (Lodish 1974; Thomas 2000). Given that there is
an excess in the number of mRNA transcripts to ribo-
somes, a decrease in ribosome number would impinge not
only on the rates of translation, but also on the patterns of
translation (Lodish 1974; Thomas 2000). This is because
as the number of ribosomes to mRNA transcripts de-
creases, those mRNAs for which the translational appa-
ratus has high affinity will continue to be translated,
whereas the translation of those mRNAs for which the
protein synthetic apparatus has low affinity will decrease
(Thomas 2000; Volarevic and Thomas 2001; Ruggero and
Pandolfi 2003). Importantly, changes in gene expression,
caused by alterations in ribosome number, have been
implicated in aberrant growth and human pathologies
(Ferreira-Cerca and Hurt 2009; Zhang and Lu 2009). Evi-
dence in support of this concept initially came from
findings in model systems showing that ribosomal pro-
teins (RPs) act as haploinsufficient tumor suppressors
(Watson et al. 1992; Stewart and Denell 1993; Amsterdam
et al. 2004). More recently, it has become evident that
patients affected by Diamond-Blackfan anemia (DBA)
(Draptchinskaia et al. 1999; Gazda et al. 2006) or 5q
syndrome (Ebert et al. 2008), pathological conditions char-
acterized by heterozygous loss-of-function mutations in
RP genes, have a propensity to develop tumors later in life
(Fumagalli and Thomas 2011).
Given the observations above, it is not surprising that
the eukaryotic cell has developed checkpoints to monitor
the fidelity and status of the translational machinery. We
initially described the existence of this checkpoint fol-
lowing the deletion of an essential 40S RP gene, RPS6, in
the liver of the adult mouse. This checkpoint blocked
the ability of hepatocytes to re-enter the cell cycle and
regenerate the lost liver mass following partial hepatec-
tomy (Volarevic and Thomas 2001). Surprisingly, deletion
of RPS6, although abrogating 40S ribosome biogenesis,
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Thomas 2001). Recently, we demonstrated that the lesion
in 40S as well as 60S ribosome biogenesis results in the
induction of p53 and G1 cell cycle arrest (Fumagalli et al.
2009). Notably, in the liver, the induction of the p53 re-
sponse is caused by the deletion of the RPS6 gene and is
not a consequence of the subsequent induction of hepa-
tocytes to dedifferentiate and re-enter the cell cycle. This
led us to conclude that it is not the number of ribosomes,
but nascent ribosome biogenesis, that the cell monitors
(Fumagalli et al. 2009). The importance of these findings
to human pathology has been underscored in DBA and
5q syndrome, for which there is increasing evidence that
the aberrant activation of the p53-dependent cell cycle
checkpoint in erythroid precursors is responsible for the
associated macrocytic anemia (Pellagatti et al. 2010; Dutt
et al. 2011; Fumagalli and Thomas 2011).
The checkpoint elicited by impairment of ribosome
biogenesis has been shown to be due to the ability of
specific RPs to bind to human double minute 2 (Hdm2),
inhibiting its E3 ligase activity, allowing p53 levels to rise
in the cell and suppress cell cycle progression (Zhang and
Lu 2009). Initially, based on studies of inhibition of rRNA
transcription with low doses of actinomycin D, this re-
sponse was attributed to nucleolar disruption and passive
diffusion from the nucleolus to the nucleoplasm of RPs,
particularly RPS7, RPL5, RPL11, and RPL23 (Dai et al.
2004; Jin et al. 2004; Chen et al. 2007; Zhu et al. 2009).
However, we recently demonstrated that p53 up-regula-
tion in response to impaired 40S or 60S ribosome bio-
genesis, despite being mediated by RPL11, does not lead
to any notable alterations in nucleolar structure, leading
to the conclusion that it is a regulated, rather than a
passive, event (Fumagalli et al. 2009). We also demon-
strated that the induction of p53 was due to the binding of
RPL11 to Hdm2 and that depletion of RPL11 abolished
this response (Fumagalli et al. 2009). This result raised
the question of the role of RPS7, RPL5, and RPL23,
which in the absence of RPL11 would have been predicted
to still bind and inhibit Hdm2, maintaining high levels
of p53.
As mentioned above, deletion of RPS6 abrogated 40S
ribosome biogenesis, but did not alter the synthesis of 60S
ribosomes (Volarevic et al. 2000). In fact, depletion of any
single RP of either the 40S or 60S ribosomal subunit does
not alter the production of the other subunit (Fumagalli
et al. 2009). This is a surprising finding, given that ribo-
some biogenesis is a highly regulated process requiring
the transcriptional coordination of all three RNA poly-
merases and expending a tremendous amount of cellular
energy (Rudra and Warner 2004). Given that the extra
ribosomal subunits generated under these conditions are
not able to contribute to the cell’s protein synthetic ca-
pacity (Volarevic et al. 2000; Fumagalli et al. 2009), the
likely prediction would have been an extension of the p53
checkpoint to halt their synthesis. That the synthesis of
either subunit is maintained, when the other is abrogated,
suggests an alternative role for ribosomal subunits be-
yond translation, in agreement with the findings of others
(Miyoshi et al. 2002; Steffen et al. 2008). Consistent with
the continued maturation of one subunit in the absence
of the other, it is known that the maturation of the two
ribosomal subunits is mediated by independent process-
ing pathways (Tschochner and Hurt 2003; Zemp and
Kutay 2007). However, despite the processing pathways
being insulated from one another, p53 in response to im-
paired 40S or 60S ribosome biogenesis is mediated by
RPL11 binding to Hdm2 (Fumagalli et al. 2009). In the
case of impaired 40S ribosome biogenesis, this effect re-
quires the translational up-regulation of RPL11 to gen-
erate sufficient RPL11 protein to bind to Hdm2 in the
face of continued 60S ribosome biogenesis and a sharp
decrease in protein synthesis rates (Fumagalli et al.
2009). In contrast, impaired 60S ribosome biogenesis
leads to an apparent suppression of RPL11 translation,
since in the absence of large subunit biogenesis, there
are sufficient RPL11 levels to bind Hdm2 (Fumagalli
et al. 2009). Thus, despite the biogenesis of both sub-
units being controlled by distinct processing path-
ways, disruption of either leads to the suppression of
Hdm2 by RPL11, suggesting a common pathway of p53
induction.
Given the importance of ribosome biogenesis to human
pathology, it is critical to identify the basic molecular
mechanisms by which this process is regulated and how
it is integrated with mechanisms that control cell cycle
progression. Here we set out to evaluate the requirement
of RPS7, RPL5, RPL11, and RPL23 in inducing the p53
response to impaired ribosome biogenesis and determine
whether this response is common for insults to either
ribosomal subunit. We demonstrate that only RPL11 and
RPL5, in a mutually dependent manner, are required for
p53 induction. Moreover, we traced the apparent differ-
ence in these findings with those of earlier reports to the
effect of long-term RP depletions on global protein syn-
thesis rates (Fumagalli et al. 2009). In carrying out these
studies, we made the unexpected observation that com-
plete abrogation of ribosome biogenesis by codepletion of
two essential RPs, one from each subunit, but not the
same subunit, leads to suprainduction of p53. Consistent
with this observation, we found that RPL11 mRNA is
still selectively up-regulated at the translational level
when the biosynthesis of both subunits is abrogated, de-
spite no competition for RPL11 protein in the biogenesis
of 60S ribosomes. Moreover, we demonstrate that the
consequence of the suprainduction of p53 is a G1 cell
cycle block and the induction of a novel G2/M cell cycle
block. Thus, the mechanisms of p53 induction following
disruption of the synthesis of either subunit are insulated
from one another and, when simultaneously engaged,
lead to full cell cycle arrest.
Results
RPL5 and RPL11 are required to induce p53
Others have recently shown that ectopic expression of
either RPL11 or RPL5 is sufficient to inhibit Hdm2 and
induce the p53 response, whereas our findings indicated
that in the absence of RPL11, endogenous RPL5 is not
sufficient to induce this response (Fumagalli et al. 2009).
Impaired ribosome biogenesis, G2 arrest
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Given studies in yeast showing that RPL5 and RPL11
are preassembled into a ribonucleoprotein particle before
being incorporated into the nascent 90S processome,
we reasoned that there may be a mutual dependence of
the two proteins for inhibition of Hdm2. Such a model
would explain the inability of RPL5 to inhibit Hdm2 in
the absence of RPL11. To test this possibility, A549
human lung carcinoma cells (ATTC, CCL-185) were first
treated with either a nonsilencing siRNA (NS siRNA)
or a siRNA specific for RPS6—in the latter case to
disrupt 40S ribosome biogenesis and induce the up-
regulation of p53. In addition, cells were treated with
siRNAs against RPL5 and RPL11, either alone or in
combination with siRNAs against RPS6. As compared
with cells treated with the control NS siRNA, those
treated with the RPS6 siRNA showed a strong induction
of p53 and its target gene, p21 (Fig. 1A), consistent with
a reduction in RPS6 mRNA levels, as measured by
quantitative qRT–PCR (qRT–PCR) (Fig. 1B), and the
disruption of 40S ribosome biogenesis, as evidenced by
the loss of native 40S ribosomes and an increase in native
60S ribosomes on polysome profiles (Fig. 1C). Likewise,
depletion of either RPL5 or RPL11 caused a reduction in
each of their transcript levels (Fig. 1B); however, in
contrast to depletion of RPS6, their depletion was paral-
leled by a disruption of 60S ribosome biogenesis, as
evidenced by the loss of native 60S ribosomes and an
increase in native 40S ribosomes (Fig. 1C). In addition, the
reduction in the amount of 60S ribosomal subunits
relative to the amount of 40S ribosomal subunits leads
to the increased formation of 43S preinitiation com-
plexes, detected as half-mer polyribosomes, apparent as
a pronounced shoulder on the right side of the 80S
monosome and polysomal peaks (Fig. 1C; Rotenberg et al.
1988). It should also be noted that depletion of any
RP leads to a decrease in total ribosomes as well as the
polysome mean size (Fig. 1C). Depletion of RPL5 or
RPL11, alone or together, has no effect on p53 levels
(Fig. 1A; Fumagalli et al. 2009). Nevertheless, when com-
bined with depletion of RPS6, depletion of RPL5 was as
efficient in suppressing the up-regulation of p53 as de-
pletion of RPL11 (Fig. 1A). It should be noted that
depletion of RPS6 leads to the translational up-regulation
of RPL5 (data not shown), as we showed for RPL11
(Fumagalli et al. 2009). Consistent with a model of mu-
tual dependence, the rise in p53 levels was not further
suppressed by codepletion of RPL5 and RPL11 (Fig. 1A).
This paradigm is not limited to disruption of 40S bio-
genesis by RPS6 depletion, as we obtained equivalent
results in cells treated with low doses of actinomycin D
(Fig. 1D), which selectively inhibits rRNA polymerase I
(Pol I) (Perry 1963). It should be noted that the induction
of p53 by actinomycin D is always much more pro-
nounced than that caused by depletion of an RP, such as
RPS6 (see below); however, the extent to which codeple-
tion of RPL11 rescues this response is qualitatively
equivalent (Fig. 1D). These findings indicate that the
effects of RPL5 and RPL11 are dependent on one another,
such that neither protein alone is sufficient to inhibit
Hdm2.
No requirement for RPS7 and RPL23
in the p53 response
RPS7 and RPL23 have been shown to bind and inhibit the
E3 ligase activity of Hdm2 toward p53 (Zhang and Lu
2009). In the presence of RPS7 and RPL23, depletion of
either RPL5 or RPL11 is sufficient to rescue inhibition of
Figure 1. p53 up-regulation induced by inhibition of ribosome
biogenesis requires RPL5 and RPL11. (A) Western blots showing
the levels of p53, p21, and b-actin proteins in A549 cells trans-
fected with the indicated siRNAs. (B) Levels of the RPS6, RPL5,
and RPL11 mRNAs in A549 cells transfected with the indicated
siRNAs, as measured by qRT–PCR. Each bar represents the
average 6 SEM of the ratio of the measurement of the indicated
mRNA to the one of b-actin mRNA, as calculated for three
independent samples. (C) Polysome profiles from extracts of A549
cells transfected with the indicated siRNAs. (D) Western blots
showing the levels of p53, p21, and b-actin proteins in A549 cells
transfected with the indicated siRNAs for 48 h and treated with
or without 5 ng/mL actinomycin D for 6 h.
Fumagalli et al.
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Hdm2 induced by impaired ribosome biogenesis, raising
the possibility that the ability of either RP to inhibit
Hdm2 is also mutually dependent on RPL5 or RPL11. To
test this, we depleted A549 cells of either RPS7 or RPL23
alone or in combination with RPS6 or RPL7a, both of
whose depletion leads to p53 induction and disruption of
40S and 60S ribosome biogenesis, respectively (Fumagalli
et al. 2009). In all cases, the extent of depletion of each RP
was verified by qRT–PCR (Fig. 2A,B). Unexpectedly, un-
like the depletion of RPL5 or RPL11, depletion of either
RPS7 or RPL23 induced a p53 response equivalent to that
observed when depleting RPs from the same ribosomal
subunit, RPS6 and RPL7a, respectively (Fig. 2A,B, respec-
tively). Moreover, the induction of p53 by depleting RPS6
or RPL7a is not suppressed by codepletion of RPS7 or
RPL23 (Fig. 2A,B, respectively), which is in contrast to
what others have shown when inducing p53 with actino-
mycin D. These findings were not unique to A549 cells,
as similar results were obtained in the U-2 OS human
osteosarcoma cell line (ATCC, HTB-96) (Fig. 2C). Un-
expectedly, codepleting two RPs, one from each of the
two ribosomal subunits, RPS7 and RPL7a or RPS6 and
RPL23, leads to the suprainduction of p53 (Figs. 2A–C).
This result was unexpected, as in our hands, depletion of
any single RP from either subunit is sufficient to elicit
a p53 response and G1 cell cycle arrest, with the excep-
tion of RPL5 and RPL11 (Figs. 1, 2; Fumagalli et al. 2009),
and implies that that the mechanisms of p53 induction are
independently regulated, depending on the subunit whose
biosynthesis is disrupted—a question analyzed later in this
study. Taken together, the results show that disruption of
either 40S or 60S ribosome biogenesis by depletion of
either RPS7 or RPL23, respectively, leads to the induction
of p53 and that depletion of neither protein suppresses the
p53 response elicited by the depletion of another RP, unlike
depletion of either RPL5 or RPL11 (Fig. 1A).
Depletion of RPS7 or RPL23 has no effect
on nucleolar integrity
The up-regulation of p53 by depletion of either RPS7 or
RPL23 was unexpected and raised the question as to the
mechanism involved. We showed previously that, dis-
tinct from the case of inhibition of Pol I transcription by
actinomycin D, up-regulation of p53 by depletion of RPs
such as RPS6 or RPL7a occurs in the absence of any
notable alterations in nucleolar structures or in the syn-
thesis of the other subunit (Fumagalli et al. 2009). In order
to determine whether the mechanism of up-regulation of
p53 by RPS7 and RPL23 depletion is similar to that of
depletion of RPS6 and RPL7a or treatment with actino-
mycin D, we analyzed the distribution of the nucleolar
protein fibrillarin by immunofluorescence. In these ex-
periments, cells were pretreated with siRNAs directed
against RPS6, RPS7, RPL7a, or RPL23. As a negative
control of nucleolar disruption, we transfected cells with
a NS siRNA, whereas for a positive control, cells were
treated with low doses of actinomycin D. The results of
these studies show that compared with cells transfected
with NS siRNA, treatment with low doses of actinomycin
D caused an increase in nuclear p53 staining, dispersion of
fibrillarin in the nucleus, and its association with nucleolar
cap structures (Fig. 3A; Hernandez-Verdun et al. 2010).
Treatment of cells with siRNAs directed against RPS6,
RPS7, RPL7a, or RPL23 also resulted in an increase in the
levels of p53 in the nucleus, but did not affect the
Figure 2. RPS7 and RPL23 are not required for the
induction of p53 by depletion of RPs. (A, top panel)
Levels of the RPS7, RPS6, and RPL7a; RPS7 and RPS6; or
RPS7 and RPL7a mRNAs in A549 cells transfected with
the indicated siRNAs, as measured by qRT–PCR. Each
bar represents the average 6 SEM of the ratio of the
measurement of the indicated mRNA to the one of
b-actin mRNA, as calculated for three independent
samples. (Bottom panel) Western blots showing the
levels of p53 and b-actin proteins in A549 cells trans-
fected with the indicated siRNAs. The b-actin blot is
stained with Ponceau; the prominent visible band mi-
grates in the position of b-actin. (B, top panel) Levels
of the RPL23, RPS6, and RPL7a; RPL23 and RPS6; or
RPL23 and RPL7a mRNAs in A549 cells transfected
with the indicated siRNAs, as measured by qRT–PCR.
Each bar represents the average 6 SEM of the ratio of
the measurement of the indicated mRNA to the one
of b-actin mRNA, as calculated for three independent
samples. (Bottom panel) Western blots showing the
levels of p53 and b-actin proteins in A549 cells trans-
fected with the indicated siRNAs. The b-actin blot is
stained with Ponceau; the prominent visible band mi-
grates in the position of b-actin. (C) Western blots
showing the levels of p53 and b-actin proteins in U-2
OS cells transfected with the indicated siRNAs. The
b-actin blots are stained with Ponceau; the prominent
visible band migrates in the position of b-actin.
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distribution of fibrillarin, which was indistinguishable
from that of NS siRNA-treated cells (Fig. 3B). Thus, even
though depletion of each RP leads to abortive processing of
either nascent 40S or 60S ribosomal subunits, the effects on
p53 are not attributed to alterations in nucleolar integrity.
Induction of p53 by depletion of RPS7 and RPL23
is RPL5/RPL11 dependent
The findings above suggest that the induction of p53 caused
by depleting RPS7 and RPL23 is due to the impairment of
either 40S or 60S ribosome biogenesis, respectively, as it
is for depletion of either RPS6 or RPL7a (Figs. 1, 2). Based
on the latter findings, we would hypothesize that the
induction of p53 triggered by depleting RPS7 or RPL23 is
mediated by the binding of RPL5 and RPL11 to Hdm2.
Consistent with this hypothesis, we previously showed
that depletion of RPS7 leads to the translational up-
regulation of RPL11 mRNA, similar to the depletion of
RPS6, whereas depletion of RPL23, like that of RPL7a,
led to the translational suppression of RPL11 mRNA
(Fumagalli et al. 2009). To test this hypothesis, we asked
whether the effect of p53 induction by depletion of RPS7
or RPL23 is reversed by codepletion of either RPL11 or
RPL5. The results show that the p53 response induced by
depletion of RPS7 or RPL23 is completely reversed by
codepletion of either RPL11 or RPL5 (Fig. 4–C, respec-
tively). These data support the notion that both RPL5
and RPL11 are necessary to mediate the induction of p53
by depletion of RPS7 or RPL23, but that neither alone is
sufficient.
Depletion of RPs has an inhibitory effect on global
protein synthesis rates
The finding that depletion of either RPS7 or RPL23 leads
to the induction, rather than suppression, of p53 was hard
to rationalize with earlier reports (Zhang and Lu 2009).
In most cases, others have evaluated the role of RPS7 or
RPL23 in suppressing p53 induction by acutely aborting
nascent ribosome biogenesis with low doses of actino-
mycin D (Zhang and Lu 2009). In contrast, we interfered
with nascent ribosome biogenesis by either deleting or
depleting individual 40S or 60S RPs. We also showed that
such treatments have a differential effect on the trans-
lation of 59TOP mRNAs, including RPL11, even though
they inhibited global protein synthesis rates to a similar
extent (Fumagalli et al. 2009). However, acute treatment
with low doses of actinomycin D would be expected to
Figure 3. Depletion of RPS7 or RPL23 does not result in nucleolar
disruption. (A) Fluorescent immunostaining with anti-p53 and anti-
fibrillarin antibodies of A549 cells transfected with NS siRNA and
then treated where indicated for 6 h with 5ng/mL actinomycin D.
(B) Fluorescent immunostaining with anti-p53 and anti-fibrillarin
antibodies of A549 cells transfected with the indicated siRNAs.
The samples were analyzed by confocal microscopy with a Plan-
Apochromat 633/1.4 oil Dic objective (Zeiss). Bar, 5 mm.
Figure 4. The up-regulation of p53 induced by depletion of
RPS7 or RPL23 is dependent on RPL5 and RPL11. (A–C) Western
blots showing the levels of p53 and b-actin proteins in A549
transfected with the indicated siRNAs.
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have little or no inhibitory effect on global protein syn-
thesis rates. Therefore, we reasoned that the suppression
of the actinomycin D-induced p53 response by depleting
RPS7 or RPL23 may instead be due to the more profound
inhibition of global protein synthesis rates, as compared
with cells treated with NS siRNA, and that the same
effect would result from the depletion of any RP essential
for ribosome biogenesis. To test this possibility, we com-
pared the effects on global translation rates of A549 cells
treated with siRNAs to RPS6, RPS7, RPL7a, RPL11, and
RPL23, as well as an NS siRNA, followed by acute
treatment with actinomycin D. The results show that
whereas actinomycin D treatment of NS siRNA trans-
fected cells had little effect on global translation, as
measured by 3H-leucine incorporation into nascent pro-
tein, depletion of any single RP had a pronounced effect
on protein synthesis (Fig. 5A). In parallel, we found that in
cells depleted of RPS6, the induction of p53 by actino-
mycin D was suppressed and equivalent to that in cells
depleted of RPS7 (Fig. 5B). A similar inhibition of p53
induction by actinomycin D was observed for cells de-
pleted of RPL7a or RPL23, whereas depletion of RPL11
completely abolished the p53 response (Fig. 5B) despite
having an inhibitory effect on protein synthesis similar to
that of depletion of other RPs (Fig. 5A). These results were
not unique for A549 cells, as we obtained similar findings
in U-2 OS cells (Fig. 5C). However, it should be noted that
the reduction in p53 levels was less pronounced when
we depleted a 40S versus a 60S RP (Fig. 5B,C). This dif-
ference most likely reflects the selective translational up-
regulation of RPL11 mRNA transcripts when cells are
depleted of a 40S RP, RPS6, and RPS7 versus a 60S RP,
RPL7a, and RPL23 (Fumagalli et al. 2009), despite a sim-
ilar inhibitory effect on global protein synthesis (Fig. 5A).
Such an increase in RPL11 would be expected to more
strongly protect p53.
If the reduction in p53 levels is due to inhibition of
global translation, this response should be recapitulated
by treating cells with a general protein synthesis in-
hibitor, such as cycloheximide. The results show that
suppression of protein synthesis by cycloheximide at
increasing doses, from 0.02 to 0.1 mg/mL (Fig. 5D), is
paralleled by a reduction in the p53 response to actino-
mycin D (Fig. 5E), similar to that observed when deplet-
ing RPs, with the exception of RPL11 (Fig. 5B,C). These
data show that the effects of RPS7 and RPL23 depletion
on p53 accumulation induced by actinomycin D are not
unique for these RPs, as equivalent effects are obtained by
depleting other RPs of the same ribosomal subunit. More
importantly, they suggest that the differences between
our findings reported here and those of others, with re-
spect to the ability of RPS7 and RPL23 depletion to
suppress the induction of p53 (Dai et al. 2004; Jin et al.
2004; Chen et al. 2007; Zhu et al. 2009), may be attributed
to a general inhibition of global protein synthesis rates,
combined with the known short half-life of p53 (Vousden
and Lane 2007).
Distinct mechanisms mediate the induction of p53
in response to impaired 40S versus 60S
ribosome biogenesis
As noted above, we unexpectedly observed that aborting
both 40S and 60S ribosome biogenesis by depleting two
essential RPs of either subunit causes a suprainduction of
p53, whereas if the two proteins depleted are of the same
subunit, the effect on p53 is equivalent to the depletion of
any single RP (Fig. 2). These effects were not unique to the
combinations used in the experiments described in Figure
2, as an equivalent result was obtained when depleting
RPS6 and RPL7a (Fig. 6A), arguing that the combined
effect is a consequence of the simultaneous impairment
Figure 5. The effects of RPS7 and RPL23 depletion on
p53 accumulation induced by actinomycin D are due to
inhibition of protein synthesis. (A) Measurement of 3H-
leucine incorporation in A549 cells transfected with
siRNAs and then treated where indicated with 5 ng/mL
actinomycin D for 6 h. Each bar represents the average
6 SEM of three independent samples. (B) Western blots
showing the levels of p53 and b-actin proteins in A549
cells treated as in A. (C) Western blots showing the
levels of p53 and b-actin proteins in U-2 OS cells
transfected with the indicated siRNAs and then treated,
where indicated, with 5 ng/mL actinomycin D for 12 h.
In both panels, the b-actin blot is stained with Ponceau;
the prominent visible band migrates in the position of
b-actin. (D) Measurement of 3H-leucine incorporation
in A549 cells transfected with NS siRNA and then
treated with 5 ng/mL actinomycin D for 6 h in the
presence of the indicated concentrations of cyclohexi-
mide. Each bar represents the average 6 SEM of three
independent samples. (E) Western blots showing the
levels of p53 and b-actin proteins in A549 cells treated
as in D. Included is a sample of A549 cells transfected
with L11 siRNA and then treated with 5ng/mL actino-
mycin D for 6 h.
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of 40S and 60S ribosome biogenesis. Surprisingly, these re-
sults suggest that the mechanisms, which sense impaired
40S and 60S ribosome biogenesis, like those involved in
the biogenesis of nascent ribosomes (Zemp and Kutay
2007), are insulated from one another and act indepen-
dently to mediate the induction of p53. If this is the case,
the prediction would be that the translational up-regula-
tion of 59TOP mRNAs, including RPL11 mRNA, which
is required to elicit a p53 response in cells where 40S
ribosome biogenesis is disrupted, is not affected by dis-
ruption of the 60S ribosome biogenesis. We would not
have foreseen this, given that we had earlier rationalized
that ongoing 60S ribosome biogenesis was the reason for
the translational up-regulation of RPL11 mRNA, regard-
less of the inhibition of global protein synthesis (Fumagalli
et al. 2009). To test this possibility, we depleted cells of
RPS6, RPL7a, or RPS6 in combination with RPL7a. The
analysis of RPL11 mRNA distribution on polysome
gradients revealed that disruption of the 40S ribosome
biogenesis following depletion of RPS6 leads to an almost
complete recruitment of RPL11 mRNA into polysomes,
as compared with NS siRNA-treated cells, despite a de-
crease in mean polysome size (Fig. 6B; Fumagalli et al.
2009). In contrast, depletion of RPL7a alone causes RPL11
transcripts to accumulate in the nonpolysome portion of
the sucrose gradient (Fig. 6B; Fumagalli et al. 2009). In
addition, depletion of RPL7a led to the appearance of half-
mer polyribosomes (Fig. 6B), as observed following de-
pletion of either RPL5 or RPL11 (Fig. 1C). Although the
appearance of half-mer polyribosomes is lost by codeple-
tion of RPS6, there is no effect on the mean polysome size
(Fig. 6B), consistent with the effects on global translation
rates, as measured by the incorporation of 3H-leucine into
nascent protein (Fig. 5A). However, the translational up-
regulation of RPL11 mRNA following RPS6 depletion is
not suppressed by codepletion of RPL7a (Fig. 6B). We
observed equivalent results when codepleting RPS6 and
RPL23 (data not shown), which also results in p53 supra-
induction (Fig. 2B,C). Moreover, as we reported previ-
ously, these effects are unique to 59TOP mRNAs (Fumagalli
et al. 2009), as we do not see a similar effect on transcripts
such as b-actin (data not shown). Therefore, even though
60S ribosome biogenesis is disrupted and RPL5 and
RPL11 are no longer being consumed in the biogenesis
of nascent 60S ribosomes, impairment of 40S ribosome
biogenesis still leads to the translational up-regulation of
RPL11 mRNA, consistent with the suprainduction of
p53. This is a surprising observation, as it demonstrates
that the checkpoint mechanisms that monitor 40S and
60S ribosomes biogenesis, despite the fact that both are
dependent on RPL5/RPL11 protein levels, are regulated
independently of one another.
Figure 6. Concomitant inhibition of 40S and 60S ribosome biogenesis has an additive effect on the accumulation of p53. (A) Western
blots showing the levels of p53, p21, and b-actin proteins in A549 cells transfected with the indicated siRNAs. (B) Quantification of the
distribution of the RPL11 mRNA along polysome profiles of A549 cells transfected with NS siRNA or RPS6 siRNA for 30 h (left panel)
and with RPL7a siRNA or RPS6 and RPL7a siRNAs (right panel). Superimposed are the traces of the polysome profiles (left panel: NS
siRNA [black] and RPS6 siRNA [gray]; right panel: RPL7a siRNAs [black] and RPS6 and RPL7a siRNAs [gray]). (C) Levels of the PUMA,
BAX, and NOXA mRNAs (left panel) and of the p21, TP53I3, and BTG2 mRNAs (right panel) in A549 cells transfected with the
indicated siRNAs, as measured by qRT–PCR. Each bar represents the average 6 SEM of the ratio of the measurement of the indicated
mRNA to the one of b-actin mRNA, as calculated for the three independent samples.
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Despite coinhibition of 40S and 60S ribosome biogen-
esis leading to the suprainduction of p53 (Fig. 6A), we
observed no evidence of increased apoptosis up to 48 h
post-siRNA treatment, as measured by either PARP or
caspase 3 cleavage (data not shown). Importantly, we
showed previously that A549 cells elicit a p53-dependent
apoptotic response to DNA-damaging agents (Beuvink
et al. 2005). To corroborate this finding, we analyzed by
qRT–PCR the mRNA levels of a number of proapoptotic
p53 target genes, including PUMA, NOXA, and BAX
(Riley et al. 2008). Amongst these genes, PUMA mRNA
was potently induced, but this effect was not enhanced by
simultaneously impairing the biogenesis of both subunits
and did not parallel the induction of p53 (Fig. 6C). More-
over, the effects on NOXA or BAX expression were
minimal, and, like PUMA, their level of induction did not
correlate with that of p53 (Fig. 6C). The modest effects on
NOXA and BAX expression are consistent with our in-
ability to detect any signs of apoptosis regardless of the
extent of inhibition of ribosome biogenesis. In contrast,
we found that the expression of p53 target genes involved
in the inhibition of cell cycle progression, all of which
were induced by impairing the synthesis of either ribo-
somal subunit, was further augmented by the simulta-
neous inhibition of both subunits (Fig. 6C). We observed
similar effects in other cell lines (data not shown), con-
sistent with the suprainduction of p53 eliciting its anti-
proliferative effects at the level of cell cycle progression.
A G2/M checkpoint revealed by coimpairment of 40S
and 60S ribosome biogenesis
The question that arises from the findings above is whether
the suprainduction of p53, caused by impairing both 40S
and 60S ribosome biogenesis, has a further consequence
on the cell beyond that elicited by impaired synthesis of
either subunit alone. We noted that actinomycin D pro-
vokes a much stronger p53 induction than disrupting
either 40S or 60S ribosome biogenesis (Figs. 1D, 3; data
not shown). In parallel, like others (Choong et al. 2009),
we found that actinomycin D elicits a block in both the
G1 and G2/M phases of the cell cycle, with virtually no
cells in S phase (Fig. 7A). In contrast, we reported that
depleting cells of RPS6 and disrupting 40S ribosome bio-
genesis leads to a strong arrest of cells in G1, but with no
apparent difference in the G2 population, and a significant
amount of cells in S phase (Fumagalli et al. 2009). This
raised the question as to whether the suprainduction of
p53 caused by impairing both 40S and 60S ribosome
biogenesis, similar to the action of actinomycin D, also
leads to arrest of cells in G2/M. We found that depletion
of either RPS6 or RPL7a leads to a G1 block and a de-
creased percentage of cells in S phase, with the level of the
G1 block not further enhanced by codepleting the two
RPs (Fig. 7B). However, disruption of both 40S and 60S
ribosome biogenesis further decreased the percentage of
cells in S phase and caused a distinct accumulation of
cells in G2/M, similar to that observed for actinomycin D
treatment (Fig. 7A). To determine whether the G2/M
response, like the G1 response, was dependent on the
induction of p53, we treated cells with NS siRNA or
siRNAs against RPS6 and RPL7a in the presence of
a siRNA directed against p53. The results show that both
the G1 and G2/M cell cycle checkpoints are relieved by
depleting cells of p53 (Fig. 7, cf. B and C). It should be
noted that depletion of p21 is not sufficient to rescue
either block (data not shown), consistent with the up-
regulation of other cell cycle inhibitors, including BTG2
and TP53I3 (Fig. 6C). These findings demonstrate that the
enforced rise in the suppression of cell cycle progression,
caused by impairing both 40S and 60S ribosome bio-
genesis, is due to the suprainduction of p53.
Discussion
The role of p53 as a tumor suppressor in humans and
other mammals is well established. Loss or mutations in
the p53 gene are found in ;50% of human tumors, and
alterations in p53 regulators such as Hdm2 and ARF are
present in many more cancers (Vousden and Prives 2009).
However, the role of p53 is not limited to that of a tumor
suppressor, as it has been shown to participate in other
cellular processes, including longevity, mitochondrial
oxidation, and glucose metabolism (Vousden and Prives
2009). Earlier studies suggested that regulation of p53
degradation by Hdm2 plays a critical part in response to
changes in the efficacy of ribosome biogenesis (Zhang and
Lu 2009). The importance of understanding the mecha-
nisms by which p53 is activated in lesions in ribosome
biogenesis is underscored by a number of diseases asso-
ciated with mutations in nucleolar components involved
in this process, including Treacher-Collins syndrome
(Jones et al. 2008), Dyskeratosis congenita (Ruggero
et al. 2003), Shwachman-Diamond syndrome (Shimamura
2006), DBA (Draptchinskaia et al. 1999; Gazda et al. 2006),
and 5q syndrome (Ebert et al. 2008). Studies over the last
year have shown that patients suffering from either DBA
(Dutt et al. 2011) or 5q syndrome (Pellagatti et al. 2010)
have elevated levels of p53. More remarkably, it was
demonstrated in mouse models of Treacher-Collins syn-
drome (Jones et al. 2008) and 5q syndrome (Pellagatti
et al. 2008) that the pathogenic phenotypes can be res-
cued in a p53+/ or p53/ background. These studies
suggest that impairment of ribosome biogenesis, the
lesion caused by these mutations, is most likely not
innately responsible for the pathology, but that the
cause is instead the unscheduled up-regulation of p53
(Fumagalli and Thomas 2011). Given the involvement of
p53 in diseases caused by impairment of ribosome bio-
genesis, it is critical to elucidate the molecular mecha-
nisms responsible for sensing the lesions in this process
and identify the downstream pathways that elicit the
RPL5/RPL11 checkpoint.
The studies presented here show that RPL5 and RPL11
cooperate to suppress Hdm2 and allow p53 levels to rise
in the cell and that although both are required, neither
one alone is sufficient to induce this response (Fig. 1). Our
findings contrast with the model proposed by Horn and
Vousden (2008), which is largely based on experiments
involving overexpression of RPL5 and RPL11. They
Impaired ribosome biogenesis, G2 arrest
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suggested that although the effect of RPL5 and RPL11 on
Hdm2 is cooperative, any single protein is sufficient to
inhibit Hdm2 (Horn and Vousden 2008). Our data argue
instead that RPL5 and RPL11 work in a complex to
inhibit Hdm2. The concept of a RPL5/RPL11 complex
is supported by studies in both bacteria (Yu and Wittmann
1973) and yeast (Zhang et al. 2007), where it has been
shown that the RPL5 and RPL11 orthologs are incorpo-
rated into nascent ribosomes as part of a complex, which
also includes 5S rRNA. In yeast (Deshmukh et al. 1993),
amphibians (Picard and Wegnez 1979), and mammals
(Steitz et al. 1988), it is known that RPL5 forms a complex
with 5S rRNA, and recently, 5S rRNA has been shown to
coimmunoprecipitate with RPL11 (Horn and Vousden
2008). In yeast, two assembly factors, Rpf2 and Rrs1, are
essential for assembling the RPL5/RPL11/5S rRNA com-
plex into the nascent 90S processome (Zhang et al. 2003).
Loss of either protein arrests 25S rRNA maturation at the
level of the 27SBs/27SB1 intermediates, equivalent to
mammalian 32S/36S precursors, which give rise to the
mature 28S rRNA (Zhang et al. 2003). Orthologs of yeast
Rpf2 and Rrs1 have been identified in the nucleolus of
human cells (Scherl et al. 2002). It will be of interest to
determine whether the human orthologs of Rpf2 and Rrs1
as well as 5S rRNA are part of the hypothetical RPL5/
RPL11 complex that binds to and inhibits Hdm2.
Figure 7. Concomitant inhibition of 40S and 60S ribosome biogenesis results in accumulation of cells in both the G1 and G2/M
phases of the cell cycle. A549 cells treated for 12 h with 5ng/mL actinomycin D (A) or transfected with the indicated siRNAs for 30 h
(B,C) were stained with propidium iodide. The distribution in the G1, S, and G2/M phases of the cell cycle was analyzed by flow
cytometry. Each bar represents the mean of three independent samples 6 SEM. Under these conditions, we depleted cells of p53 mRNA
>84% and reduced p53 protein to less than basal levels, as measured by qRT–PCR and Western blot analysis, respectively (data not
shown). (D) Model of stabilization of p53 in response to impairment of 40S, 60S, or both 40S and 60S ribosome biogenesis. The top left
panel shows that under normal conditions, the majority of newly synthesized RPL11 is used in the synthesis of 60S ribosomes. The top
middle panel shows that upon impairment of 40S ribosome biogenesis, there is a need to translationally up-regulate RPL11 protein
expression to bind to Hdm2 to compete for the requirement of RPL11 protein in ongoing 60S ribosome biogenesis. In contrast, the top
right panel shows that following impairment of 60S ribosome biogenesis, there is no need to up-regulate RPL11 protein expression to
bind to Hdm2, as there is no competition for RPL11 protein, as 60S ribosome biogenesis has been abrogated. The bottom middle panel,
which is drawn at slightly larger scale than the top ones, shows that despite abrogation of 60S ribosome biogenesis, coimpairment of
40S ribosome biogenesis still results in the translational up-regulation of RPL11, resulting in higher accumulation of free RPL11, as
compared with impairing either 40S or 60S ribosome biogenesis alone. This leads to a more potent inhibition of Hdm2, suprainduction
of p53, and accumulation of cells in both G1 and G2/M. The RPL11 proteins that either bind Hdm2 or are used in the synthesis of 60S
ribosomes are represented in violet and pink, respectively. For simplicity, only RPL11 and not RPL5 are shown. The thickness of the
black lines is directly proportional to the intensity of the stimulatory (/) or inhibitory (—j) effects.
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Our findings suggest that neither RPS7 nor RPL23 is
required for the suppression of Hdm2 and the induction of
p53 caused by depletion of RPs (Fig. 2). We demonstrated
previously that depleting the RPS7 level was as efficient
in inducing the translational up-regulation of 59TOP
mRNAs, including RPL11 mRNA, as depleting RPS6
(Fumagalli et al. 2009). Consistent with these findings,
we show that depleting RPS7 induces, rather than sup-
presses, the induction of p53, a response that is dependent
on RPL5 and RPL11 (Fig. 4A) and occurs in the absence of
alterations to nucleolar structures (Fig. 3). We observed
the same response in three different cell lines, including
A549, U-2 OS, and HCT116 (Fig. 4A; S Fumagalli and G
Thomas, unpubl.). We observed the same effects of de-
pleting RPL23 as we observed for depleting RPS7, (Figs.
2B,C, 3, 4; S Fumagalli and G Thomas, unpubl.). We found
that RPL23 or RPS7 depletion partially suppresses p53 up-
regulation by actinomycin D; however, these effects are
equivalent to those of depleting a second RP of the 60S or
40S ribosome, respectively (Fig. 5B,C). We propose that
inhibition of ribosome biogenesis caused by RPL23 or
RPS7 depletion results in suppression of protein synthe-
sis, similar to cycloheximide treatment, and that in paral-
lel, this leads to an apparent inhibition on p53 induction by
actinomycin D (Fig. 5A,D,E). It should be noted that Dai
et al. (2004) have demonstrated previously that reducing
RPL23 levels leads to the induction of p53, whereas in
parallel, they found that the induction of p53 by actino-
mycin D was suppressed by depletion of RPL23. The
investigators suggested that the first response may have
been through an insult to ribosome biogenesis through an
as yet unidentified pathway (Dai et al. 2004). However,
the findings presented here would explain the apparent
conundrum, with depletion of RPL23 inducing p53
through a canonical RPL5/RPL11-dependent pathway,
and the suppression of the actinomycin D-induced p53
response due to the inhibition of global translation rates
(Fig. 5), rather than a specific effect of RPL23 on p53
stability. It also should be noted that RPL23 binds to a
region on Hdm2 that is distinct from that bound by RPL5
and RPL11 (Dai and Lu 2004; Jin et al. 2004). Consistent
with our findings, Macias et al. (2010) have recently dem-
onstrated that a mutant of MDM2 that binds RPL23, but
not RPL5/RPL11, can still drive p53 degradation in cells
treated with agents that cause inhibition of rRNA tran-
scription, including actinomycin D. These findings show
that binding of RPL23 to MDM2 is not sufficient to
stabilize p53. Nevertheless, given that RPS7 and RPL23
interact with Hdm2 (Dai et al. 2004; Jin et al. 2004; Chen
et al. 2007; Zhu et al. 2009), we cannot rule out that they
may have a role in mediating Hdm2 function distinct
from that of the induction of p53. In this context, it is
important to note that RPs are highly basic proteins and
the central domain of Hdm2 is very acidic, such that
conclusions based on overexpression of RP genes may be
misleading. Analyses of point mutations that alter the
ability of RPS7 and RPL23 to bind Hdm2 would be useful
in resolving these issues.
Our initial observation that disruption of 40S ribosome
biogenesis in liver does not alter the rates of 60S ribosome
biogenesis was unexpected (Volarevic et al. 2000). This
observation has been confirmed in other mammalian
systems (Fumagalli et al. 2009; O’Donohue et al. 2010)
as well as in yeast (Zemp and Kutay 2007). It is well es-
tablished that the 40S and 60S ribosome biogenesis are
handled by distinct processing pathways (Poll et al. 2009).
The unexpected observation that disruption of both
pathways in concert led to suprainduction of p53 led us
to suspect that the underlying molecular mechanisms,
which sense damage to the processing of either ribosomal
subunit, were distinct from one another. Although we
cannot exclude that the effects observed are confined to
unique properties of the combination of RPs that we
analyzed, in the case of codepletion of RPS6 and RPL7a,
the suprainduction of p53 was found to be dependent on
RPL11 (data not shown). However, the requirement for
both proteins is less dependent on translation in cases
where 60S ribosome biogenesis is impaired as compared
with impairment of 40S ribosome biogenesis (Fumagalli
et al. 2009). This is evidenced in the latter case by the
translational up-regulation of RPL11 mRNA and the
higher sensitivity of the p53 response to a general in-
hibitor of global translation (Fumagalli et al. 2009). These
studies clearly show that the mechanisms that respond to
each insult do so through RPL5 and RPL11, but do not
rely on one another (see the model in Fig. 7D). This is a
surprising observation because, insofar as protein synthe-
sis is concerned, the effects of impairing the biogenesis of
either ribosomal subunit are equivalent to that of impair-
ing that of both ribosomal subunits. Interestingly, we
found that the suprainduction of p53 by concomitant
inhibition of 40S and 60S ribosome biogenesis is associ-
ated with a selective supra-up-regulation of p53 targets
involved in cell cycle arrest but not of those involved in
apoptosis. This is consistent with the effects of supra-
induction of p53 having an effect on cell cycle (Figs. 7A,B)
but not survival (data not shown). It is known that target
specificity of p53 is regulated at the level of post-trans-
lational modification of p53, such as acetylation and
phosphorylation, as well as by its interaction with co-
factors (Vousden and Prives 2009). It will be interesting to
determine which mechanisms (Vousden and Prives 2009)
are responsible for the selective effects of p53 on gene
expression in systems of inhibition of ribosome biogene-
sis. Interestingly, the suprainduction of p53 correlates
with a selective accumulation of cells in G2/M, arguing
that a threshold of p53 response exists beyond which not
only a G1, but also a G2/M, checkpoint is activated. In
support of this hypothesis, we observed that incomplete
depletion of p53 rescues the G2/M but not the G1
checkpoint in cells codepleted of RPS6 and RPL7a (data
not shown).
The fact that p53 induction and cell cycle arrest elicited
by impairing the synthesis of either subunit does not
extend to inhibiting the synthesis of the other subunit is
consistent with both subunits playing an essential role
beyond that of protein synthesis. In yeast, it was demon-
strated that a defect in the secretory pathway, which is
required for cell wall growth, leads to the coordinate
transcriptional suppression of ribosome biogenesis (Zhao
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et al. 2003). This response is selectively suppressed by
impaired 60S but not 40S ribosome biogenesis or global
protein synthesis (Zhao et al. 2003). Moreover, suppres-
sion of this checkpoint is only observed when interfering
with an early and not a late step of 60S ribosome bio-
genesis, arguing that it is pre-60S ribosomes that are
critical, but at an early processing step. Interestingly, the
loss of Rrs1, required for the assembly of the RPL5/RPL11
complex into the 60S subunit, also suppresses the secre-
tory checkpoint (Miyoshi et al. 2002). Recent studies in
yeast demonstrate that inhibition of 60S ribosome bio-
genesis, but not 40S ribosome biogenesis or protein syn-
thesis, increases replicative life span, the number of
mitotic cycles completed by a mother cell before senes-
cence (Steffen et al. 2008). Thus, it may be that both
ribosomal subunits play essential roles that are distinct
from one another and that are not related to protein
synthesis, which would explain how impairment of either
does not suppress the synthesis of the other.
Materials and methods
Cell culture, siRNA transfection, and drug treatments
A549 and U-2 OS cells were cultured in Dulbecco Modified
Essential Medium containing 4500 mg/mL L-glucose and 110
mg/L sodium pyruvate supplemented with 10% fetal calf serum
and 2 mM L-glutamine. Transfection of siRNAs (Qiagen) was
performed by using the calcium phosphate method as described
(Fumagalli et al. 2009). For transfection in 6-cm dishes, 20 pmol
of each siRNA was used. For each treatment, the total amount of
siRNA was adjusted to the same value by the addition of NS
siRNA (Qiagen). The target sequences of the siRNAs for human
RPS6, RPS7, RPL7a, RPL11, RPL23, and p53 have been published
(Fumagalli et al. 2009). The target sequence of the RPL5 siRNA
is 59-ACGCTTGGTGATACAAGATAA-39. Cells were treated
with drugs and processed for analyses 48 h after transfection
unless indicated otherwise. Actinomycin D is from Sigma (catalog
no. A9415), and cycloheximide is from Calbiochem (catalog no.
239763)
Antibodies
The rabbit anti-p53 antibody and mouse monoclonal anti-p21
antibody used for Western blots have been previously described
(Fumagalli et al. 2009). The same rabbit anti-p53 antibody was
used for the immunofluorescences at a 1:500 dilution. The anti-
b-actin antibody is from Cell Signaling (catalog no. 4967) and was
used at a 1:1000 dilution. The mouse monoclonal anti-fibrillarin
antibody is from Thermo Scientific (catalog no. MAI-22000) and
was used at a 1:500 dilution. Secondary antibodies for both
Western blot and immunofluorescence have been used as
described (Fumagalli et al. 2009).
Protein extraction and Western blot analysis
Preparation of protein extracts and Western blot analysis have
been performed as described (Fumagalli et al. 2009).
Immunofluorescence
Fixation of cells, staining with antibodies, and analysis by
confocal microscopy were performed as described (Fumagalli
et al. 2009).
Polysome profiling
Preparation of the cellular extracts for polysome profiling and
analysis of distribution of L11 mRNA have been performed as
described (Fumagalli et al. 2009).
Labeling of cells with 3H-leucine
Cells were incubated with 10 mCi/mL 3H-leucine (Perkin Elmer,
catalog no. NET116600) for 30 min. Cells were washed with
phosphate-buffered saline (PBS) and then incubated with cold
10% trichloroacetic acid (TCA) for 10 min. TCA-insoluble pro-
teins were then washed twice with 5% TCA, solubilized with
0.1 M NaOH, and analyzed using a liquid scintillation counter
(Tri-Carb 2100TR, Perkin Elmer).
Analysis of mRNA expression by qRT–PCR
RNA purification was performed by using the RNAeasy kit from
Qiagen (catalog no. 74104). Reverse transcription was performed
as previously described (Fumagalli et al. 2009). The resulting
cDNAs were used in qRT–PCR reactions containing Fast SYBR
Green master mix from Applied Biosystems (catalog no.
4385612). The reactions were analyzed in an Applied Biosystems
7500 Fast Real-Time PCR system. The standard curves were
generated for each assay using the PCR-amplified fragments of
the targets. Reactions were performed on the following cycle: 20
sec at 95°C, followed by 40 cycles of 3 sec at 95°C, and 30 sec at
60°C. Melt-curve analysis was performed after each run to verify
the production of a single product. The primers used were L5
forward primer, 59-GGTGTGAAGGTTGGCCTGAC-39; L5 re-
verse primer, 59-GGCACCTGGCTGACCATCAA-39; b-actin
forward primer, 59-AATGTGGCCGAGGACTTTGATTGC-39;
b-actin reverse primer, 59-AGGATGGCAAGGGACTTCCTGT
AA-39; S7 forward primer, 59-AGTTCAGTGGGAAGCATGTC
GTCT-39; S7 reverse primer, 59-AAGACCAAGTCCTCAAGGA
TGGCA-39; L23 forward primer, 59-TCCAGCAGTGGTCATTC
GACAA-39; L23 reverse primer, 59-TGCTACTGGTCCTGTAA
TGGCA-39; PUMA forward primer, 59-TTGCGATTGGGTGA
GACCCAGTAA-39; PUMA reverse primer, 59-TTACTTCCTGCC
CTGCTCTGGTTT-39; BAX forward primer, 59-TCTACTTTGCC
AGCAAACTGGTGC-39; BAX reverse primer, 59-TGTCCAGCC
CATGATGGTTCTGAT-39; NOXA forward primer, 59-TCTCAG
GAGGTGCACGTTTCATCA-39; NOXA reverse primer, 59-ATTC
CATCTTCCGTTTCCAAGGGC-39; p21 forward primer, 59-AAA
TCGTCCAGCGACCTTCCTCAT-39; p21 reverse primer 59-TCT
GACTCCTTGTTCCGCTGCTAA-39; TP53I3 forward primer, 59-
AAGCGAGGAAGTCTGATCACCAGT-39; TP53I3 reverse primer,
59-AGGCAGAATTTGCTCCGTGAAAGC-39; BTG2 forward
primer, 59-TTCCCAGACCTGCTTCCAGTCTTT-39; and BTG2
reverse primer, 59-ACAAGATGCAAGAACACAGCCTGC-39.
The primers for RPS6, RPL7a, and RPL11 have been previously
described (Fumagalli et al. 2009).
Flow cytometry
Staining of fixed cells with propidium iodide and flow cytometry
analysis were performed as described (Fumagalli et al. 2009).
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